Marciana L. Laster, MD, MS

Marciana L. Laster, MD, MS

Pediatric Nephrology
Accepting new patients
Primary Location
Children's Heart Center
200 Medical Plaza
Suite 330
Los Angeles, California 90095


Dr. Marciana Laster is a Board Certified Pediatrician and Pediatric Nephrologist at UCLA Mattel Children's Hospital. Dr. Laster received her MD degree from Northwestern University Feinberg School of Medicine in Chicago, IL after which she completed a pediatric residency at Los Angeles County+USC Medical Center. She then matriculated to UCLA for a fellowship in Pediatric Nephrology where she received research training including a Master of Science in Clinical Research. After training, Dr. Laster remained at UCLA as faculty where her research examined the impact of race and ethnicity on the manifestations of pediatric bone disease under research support from the National Institute of Health.




Medical Board Certifications

Pediatric Nephrology, American Board of Pediatrics, 2018
Pediatrics, American Board of Pediatrics, 2014


UCLA School of Medicine, 2017


LAC + USC Medical Center, 2014


LAC + USC Medical Center, 2012


UCLA School of Medicine, MS, 2017
Northwestern University Feinberg School of Medicine, MD, 2011


  • Super Doctors® Southern California Rising Stars 2021


Hospital Affiliations

Ronald Reagan UCLA Medical Center

UCLA Santa Monica Medical Center

Areas of Focus

Renal replacement therapy education
Medical management of chronic kidney disease (ckd)
Kidney disease
Chronic kidney disease (ckd)



  1. Race and ethnicity predict bone markers and fracture in pediatric patients with chronic kidney disease.
    Laster M, Denburg M, Okuda Y, Kumar J, Furth S, Warady B, Kalantar-Zadeh K, Norris K, Salusky IB.
    J Bone Miner Res. 2020 Sep 22. doi: 10.1002/jbmr.4182. Online ahead of print.
    PMID: 32960469
  2. Association of age with risk of first and subsequent allograft failure and mortality among young kidney transplant recipients in the USA - a retrospective cohort study.
    Okuda Y, Streja E, Rhee CM, Tantisattamo E, Reddy U, Laster M, Tang Y, Rajpoot D, Molnar MZ, Ichii H, Obi Y, Kalantar-Zadeh K.
    Transpl Int. 2020 Aug 11. doi: 10.1111/tri.13717. Online ahead of print.
    PMID: 32779214
  3. Primary causes of kidney disease and mortality in dialysis-dependent children.
    Okuda Y, Soohoo M, Ishikura K, Tang Y, Obi Y, Laster M, Rhee CM, Streja E, Kalantar-Zadeh K.
    Pediatr Nephrol. 2020 May;35(5):851-860. doi: 10.1007/s00467-019-04457-7. Epub 2020 Feb 4.
    PMID: 32020338
  4. Unraveling the osteocyte in CKD-MBD post-renal transplantation.
    Laster M, Pereira RC, Salusky IB.
    Kidney Int. 2019 Nov;96(5):1059-1061. doi: 10.1016/j.kint.2019.07.021.
    PMID: 31648693
  5. Serum albumin and hospitalization among pediatric patients with end-stage renal disease who started dialysis therapy.
    Okuda Y, Obi Y, Streja E, Laster M, Rhee C, Langman CB, Jernigan SM, Salusky IB, Tentori F, Schreiber MJ, Brunelli SM, Kalantar-Zadeh K.
    Pediatr Nephrol. 2019 Oct;34(10):1799-1809. doi: 10.1007/s00467-019-04270-2. Epub 2019 Jun 19.
    PMID: 31218394
  6. Racial differences in bone histomorphometry in children and young adults treated with dialysis.
    Laster M, Pereira RC, Salusky IB.
    Bone. 2019 Oct;127:114-119. doi: 10.1016/j.bone.2019.06.004. Epub 2019 Jun 7.
    PMID: 31181383
  7. Estimated GFR at Dialysis Initiation and Mortality in Children and Adolescents.
    Okuda Y, Soohoo M, Tang Y, Obi Y, Laster M, Rhee CM, Streja E, Kalantar-Zadeh K.
    Am J Kidney Dis. 2019 Jun;73(6):797-805. doi: 10.1053/j.ajkd.2018.12.038. Epub 2019 Mar 2.
    PMID: 3083308
  8. Racial-ethnic differences in chronic kidney disease-mineral bone disorder in youth on dialysis.
    Laster M, Soohoo M, Streja E, Elashoff R, Jernigan S, Langman CB, Norris KC, Salusky IB, Kalantar-Zadeh K.
    Pediatr Nephrol. 2019 Jan;34(1):107-115. doi: 10.1007/s00467-018-4048-6. Epub 2018 Sep 29.
    PMID: 30267239


  • Super Doctors® Southern California Rising Stars 2021